Green Cross Cell Corp. | Mutual Funds
Mutual Funds that own Green Cross Cell Corp.
iShares Core MSCI Emerging Markets ETF
127,710
1.09%
0
0.01%
09/05/2018
99,460
0.85%
0
1.22%
09/06/2018
Vanguard Total International Stock Index Fund
77,973
0.67%
0
0%
07/31/2018
Canada Pension Plan
33,000
0.28%
2,000
0%
03/31/2018
Vanguard Developed Markets Index Fund
30,014
0.26%
0
0%
07/31/2018
21,074
0.18%
264
0.41%
09/06/2018
Vanguard FTSE All World (ex-US) Small Cap
13,783
0.12%
0
0.01%
07/31/2018
Schwab International Small Cap Equity ETF
9,797
0.08%
0
0.02%
09/06/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
9,223
0.08%
0
0.01%
09/05/2018
Luxcellence - Polunin Emerging Markets Technology Fund
6,639
0.06%
0
1.22%
06/30/2017
| Address |
6/F, SJ Technoville
Seoul SL 08511
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.greencrosscell.com |
| Updated |
09/14/2018 |
| Green Cross Cell Corp. engages in the provision of anti-cancer immunotherapy. It operates through following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation and KGMP Service. The company was founded on September 17, 1992 and is headquartered in Seoul, South Korea. |
